Sinotruk (Hong Kong) Limited - 3808.HK

3808.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
3808.HK	2.4	4.9	4.9	5.8	31.2	58.6	86.6	46.1	460.3	118.2
S&P 500	1.0	3.7	2.2	2.3	8.9	23.9	32.3	80.6	196.5	33856.2

Compare 3808.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	3808.HK
name	Sinotruk (Hong Kong) Limited
price	23.7
changes percentage	2.3758
change	0.55
day low	23.15
day high	24.05
year high	25.6
year low	13.86
market cap	64787979000
price avg 50	22.1448
price avg 200	20.61345
exchange	HKSE
volume	740000
avg volume	3071896
open	23.15
previous close	23.15
eps	2.42
pe	9.79
earnings announcement	2025-03-24T10:59:00.000+0000
shares outstanding	2733670000
timestamp	2025-01-20 02:44:28

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 72.3%

Overall Quarterly Financial Health: 53.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	85498035000	59290569000	44.20
gross profit	14235533000	9950024000	43.07
gross profit ratio	0.17	0.17	-0.78
research and development expenses	2523163000	2582284000	-2.29
operating expenses	7748432000	7070337000	9.59
interest income	313874000	128585000	144.10
interest expense	29413000	9389000	213.27
ebitda	8484587000	3494656000	142.79
ebitdaratio	0.1	0.06	68.37
operating income	6487101000	2143803000	202.60
operating income ratio	0.08	0.04	109.84
net income	5318107000	1672662000	217.94
net income ratio	0.06	0.03	120.48
eps	1.93	0.65	196.92

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 85,498 million in 2023 from 59,291 million in 2022 representing a change of 44.2%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 14,236 million in 2023 from 9,950 million in 2022 representing a change of 43.07%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 8,485 million in 2023 from 3,495 million in 2022 representing a change of 142.79%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 6,487 million in 2023 from 2,144 million in 2022 representing a change of 202.6%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 5,318 million in 2023 from 1,673 million in 2022 representing a change of 217.94%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.93 in 2023 from 1.93 in 2022 representing a change of 196.92%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 2,523 million in 2023 from 2,582 million in 2022 representing a change of -2.29%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 7,748 million in 2023 from 7,070 million in 2022 representing a change of 9.59%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	48823239000	44108874000	10.69
gross profit	7142276000	7330920000	-2.57
gross profit ratio	0.15	0.17	-11.98
research and development expenses	0	2523163000	-100.00
operating expenses	3116113000	3913994000	-20.39
interest income	0	193779000	-100.00
interest expense	0	0	NaN
ebitda	4870331000	3828235000	27.22
ebitdaratio	0.1	0.09	14.94
operating income	4026163000	3416926000	17.83
operating income ratio	0.08	0.08	6.45
net income	3294302000	2945005000	11.86
net income ratio	0.07	0.07	1.06
eps	1.2	1.07	12.15

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 48,823 million in 2024Q2 from 44,109 million in 2023Q4 representing a change of 10.69%. This indicates a sales growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 3,116 million in 2024Q2 from 3,914 million in 2023Q4 representing a change of -20.39%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 4,870 million in 2024Q2 from 3,828 million in 2023Q4 representing a change of 27.22%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 4,026 million in 2024Q2 from 3,417 million in 2023Q4 representing a change of 17.83%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 3,294 million in 2024Q2 from 2,945 million in 2023Q4 representing a change of 11.86%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.2 in 2024Q2 from 1.2 in 2023Q4 representing a change of 12.15%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 7,142 million in 2024Q2 from 7,331 million in 2023Q4 representing a change of -2.57%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q2 from 2,523 million in 2023Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	121785488000	105478517000	15.46
total liabilities	73824957000	62509940000	18.10
total equity	47960531000	42968577000	11.62
cash and cash equivalents	15251508000	15262260000	-0.07
short term investments	32937091000	24384431000	35.07
long term investments	2049492000	2002639000	2.34
total current assets	87066767000	79757567000	9.16
total non current assets	34718721000	20110918000	72.64
total current liabilities	72530061000	61314418000	18.29
total non current liabilities	1294896000	1195522000	8.31
common stock	16717024000	16717024000	0.00
retained earnings	25014119000	20631039000	21.25
total debt	5051571000	3891859000	29.80

Overall Score of Annual Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 121,785 million in 2023 from 105,479 million in 2022 representing a change of 15.46%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 47,961 million in 2023 from 42,969 million in 2022 representing a change of 11.62%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 32,937 million in 2023 from 24,384 million in 2022 representing a change of 35.07%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 87,067 million in 2023 from 79,758 million in 2022 representing a change of 9.16%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 25,014 million in 2023 from 20,631 million in 2022 representing a change of 21.25%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 73,825 million in 2023 from 62,510 million in 2022 representing a change of 18.1%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 15,252 million in 2023 from 15,262 million in 2022 representing a change of -0.07%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 72,530 million in 2023 from 61,314 million in 2022 representing a change of 18.29%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 5,052 million in 2023 from 3,892 million in 2022 representing a change of 29.8%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	132739774000	121785488000	8.99
total liabilities	84643970000	73824957000	14.65
total equity	48095804000	47960531000	0.28
cash and cash equivalents	15723705000	15251508000	3.10
short term investments	24558271000	32937091000	-25.44
long term investments	1526934000	2049492000	-25.50
total current assets	94455610000	87066767000	8.49
total non current assets	38284164000	34718721000	10.27
total current liabilities	83289784000	72530061000	14.83
total non current liabilities	1354186000	1294896000	4.58
common stock	16717024000	16717024000	0.00
retained earnings	25642609000	19952019000	28.52
total debt	7596238000	5051571000	50.37

Overall Score of Quarterly Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 132,740 million in 2024Q2 from 121,785 million in 2023Q4 representing a change of 8.99%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 48,096 million in 2024Q2 from 47,961 million in 2023Q4 representing a change of 0.28%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 15,724 million in 2024Q2 from 15,252 million in 2023Q4 representing a change of 3.1%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 94,456 million in 2024Q2 from 87,067 million in 2023Q4 representing a change of 8.49%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 25,643 million in 2024Q2 from 19,952 million in 2023Q4 representing a change of 28.52%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 84,644 million in 2024Q2 from 73,825 million in 2023Q4 representing a change of 14.65%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 24,558 million in 2024Q2 from 32,937 million in 2023Q4 representing a change of -25.44%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 83,290 million in 2024Q2 from 72,530 million in 2023Q4 representing a change of 14.83%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 7,596 million in 2024Q2 from 5,052 million in 2023Q4 representing a change of 50.37%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-65137000	-9430144000	99.31
operating cash flow	11368355000	10895020000	4.34
free cash flow	8808804000	9455122000	-6.84
capital expenditure	-2559551000	-1439898000	-77.76
depreciation and amortization	1572493000	1412692000	11.31
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	0	-2145206000	100.00
inventory	-644430000	2305184000	-127.96
acquisitions net	0	-504375000	100.00
investments in property plant and equipment	-2547777000	-1439898000	-76.94
net cash used for investing activites	-11059192000	-18606260000	40.56
debt repayment	403531000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	-75106000	100.00
dividends paid	-812222000	-1555910000	47.80
net cash used provided by financing activities	-470962000	-1847344000	74.51
cash at end of period	15251508000	15262260000	-0.07
accounts receivables	-3513097000	6186976000	-156.78
cash at beginning of period	15316645000	24692404000	-37.97

Overall Score of Annual Cashflow Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -65 million in 2023 from -9,430 million in 2022 representing a change of 99.31%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 11,368 million in 2023 from 10,895 million in 2022 representing a change of 4.34%. This indicates that the company generated more cash from its core business operations.

  Capital Expenditure: Capital Expenditure decreased to -2,560 million in 2023 from -1,440 million in 2022 representing a change of -77.76%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 2,145 million in 2022 representing a change of 100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -3,513 million in 2023 from 6,187 million in 2022 representing a change of -156.78%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -812 million in 2023 from -1,556 million in 2022 representing a change of 47.8%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Free Cash Flow: Free Cash Flow decreased to 8,809 million in 2023 from 9,455 million in 2022 representing a change of -6.84%. This indicates a decrease in cash generated after accounting for capital expenditures.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	5336474000	8333200999	-35.96
free cash flow	4505723000	7057309999	-36.16
capital expenditure	-830751000	-1275891000	34.89
depreciation and amortization	876207000	903582000	-3.03
deferred income tax	0	0	NaN
stock based compensation	549000	0	NaN
accounts receivables	0	-3513097000	100.00
accounts payables	0	0	NaN
inventory	0	-644430000	100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	-830751000	-1275891000	34.89
net cash used for investing activites	-4531584000	-3927583000	-15.38
debt repayment	174445000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-512380000	0	NaN
dividends paid	0	-812222000	100.00
net cash used provided by financing activities	-429355000	-535293000	19.79
net change in cash	15723705000	-167050000	9512.57
cash at end of period	15723705000	11317692000	38.93
cash at beginning of period	0	11484742000	-100.00

Overall Score of Quarterly Cashflow Statement

0.29 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 15,724 million in 2024Q2 from -167 million in 2023Q4 representing a change of 9512.57%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Dividends Paid: Dividends Paid increased to 0 million in 2024Q2 from -812 million in 2023Q4 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 5,336 million in 2024Q2 from 8,333 million in 2023Q4 representing a change of -35.96%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 4,506 million in 2024Q2 from 7,057 million in 2023Q4 representing a change of -36.16%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -831 million in 2024Q2 from -1,276 million in 2023Q4 representing a change of 34.89%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 1 million in 2024Q2 from 0 million in 2023Q4 representing a change of nan%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024Q2 from -3,513 million in 2023Q4 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	30.97	21.47	44.20
net income per share	1.93	0.61	217.94
operating cash flow per share	4.12	3.95	4.34
free cash flow per share	3.19	3.42	-6.84
cash per share	17.45	14.36	21.55
book value per share	17.37	15.56	11.62
tangible book value per share	17.29	15.45	11.89
shareholders equity per share	14.59	13.01	12.15
interest debt per share	1.84	1.41	30.24
market cap	38326599047.95	26524973447.51	44.49
enterprise value	28126662047.95	15154572447.51	85.60
pe ratio	7.21	15.86	-54.55
price to sales ratio	0.45	0.45	0.20
pocfratio	3.37	2.43	38.48
pfcf ratio	4.35	2.81	55.09
pb ratio	0.95	0.74	28.84
ptb ratio	0.95	0.74	28.84
ev to sales	0.33	0.26	28.71
enterprise value over ebitda	3.32	4.34	-23.56
ev to operating cash flow	2.47	1.39	77.87
ev to free cash flow	3.19	1.6	99.22
earnings yield	0.14	0.06	120.04
free cash flow yield	0.23	0.36	-35.52
debt to equity	0.13	0.11	15.74
debt to assets	0.04	0.04	12.42
net debt to ebitda	-1.2	-3.25	63.05
current ratio	1.2	1.3	-7.72
interest coverage	220.55	228.33	-3.41
income quality	1.65	6.06	-72.76
dividend yield	0.02	0.06	-63.87
payout ratio	0.15	0.93	-83.58
sales general and administrative to revenue	0.05	0.08	-32.17
research and ddevelopement to revenue	0.03	0.04	-32.24
intangibles to total assets	0.0	0.0	-36.47
capex to operating cash flow	0.23	0.13	70.36
capex to revenue	0.03	0.02	23.27
capex to depreciation	1.63	1.02	59.69
stock based compensation to revenue	0	0	NaN
graham number	25.14	13.31	88.83
roic	0.1	0.03	194.51
return on tangible assets	0.04	0.02	175.08
graham net net	-4.29	-4.05	-5.97
working capital	14536706000	18443149000	-21.18
tangible asset value	47739526000	42667278000	11.89
net current asset value	13241810000	17247627000	-23.23
invested capital	30589573000	36551428000	-16.31
average receivables	8051220000	6935699000	16.08
average payables	39947578000	35374816500	12.93
average inventory	13417423000	15081801500	-11.04
days sales outstanding	40.59	40.6	-0.02
days payables outstanding	238.8	246.13	-2.97
days of inventory on hand	68.32	99.84	-31.57
receivables turnover	8.99	8.99	0.02
payables turnover	1.53	1.48	3.07
inventory turnover	5.34	3.66	46.14
roe	0.13	0.05	183.50
capex per share	0.93	0.52	77.76

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 7.21 on 2023-12-31 from 15.86 on 2022-12-31, representing a change of -54.55%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.20 on 2023-12-31 from 1.30 on 2022-12-31, representing a change of -7.72%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.13 on 2023-12-31 from 0.11 on 2022-12-31, representing a change of 15.74%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
3808.HK
calendar year	2024	2023	NaN
revenue per share	17.75	15.98	11.11
net income per share	1.2	1.07	12.28
operating cash flow per share	1.94	3.02	-35.72
free cash flow per share	1.64	2.56	-35.91
cash per share	14.64	17.45	-16.09
book value per share	17.49	17.37	0.66
tangible book value per share	17.41	16.48	5.68
shareholders equity per share	14.68	14.59	0.68
interest debt per share	2.76	1.83	50.94
market cap	50710922378.46	38326629018.01	32.31
enterprise value	42583455378.46	28126692018.01	51.40
pe ratio	3.85	3.25	18.28
price to sales ratio	1.04	0.87	19.54
pocfratio	9.5	4.6	106.61
pfcf ratio	11.25	5.43	107.24
pb ratio	1.26	0.95	31.92
ptb ratio	1.26	0.95	31.92
ev to sales	0.87	0.64	36.78
enterprise value over ebitda	8.74	7.35	19.00
ev to operating cash flow	7.98	3.38	136.42
ev to free cash flow	9.45	3.99	137.14
earnings yield	0.06	0.08	-15.46
free cash flow yield	0.09	0.18	-51.75
debt to equity	0.19	0.13	49.93
debt to assets	0.06	0.04	37.96
net debt to ebitda	-1.67	-2.66	37.37
current ratio	1.13	1.2	-5.53
interest coverage	0	0	NaN
income quality	1.62	2.83	-42.75
dividend yield	0	0.02	-100.00
payout ratio	0	0.28	-100.00
sales general and administrative to revenue	0.05	0.06	-18.56
research and ddevelopement to revenue	0	0.06	-100.00
intangibles to total assets	0.0	0.02	-92.35
capex to operating cash flow	0.16	0.15	1.68
capex to revenue	0.02	0.03	-41.18
capex to depreciation	0.95	1.41	-32.85
stock based compensation to revenue	0.0	0	NaN
graham number	19.89	18.71	6.32
roic	0.06	0.05	12.10
return on tangible assets	0.02	0.02	0.70
graham net net	-9.6	-4.29	-124.02
working capital	11165826000	14536706000	-23.19
tangible asset value	47889657000	45488101000	5.28
net current asset value	9811640000	13241810000	-25.90
invested capital	29303061000	32840998000	-10.77
average receivables	None	None	NaN
average payables	None	None	NaN
average inventory	None	None	NaN
days sales outstanding	27.9	19.4	43.79
days payables outstanding	112.64	114.09	-1.28
days of inventory on hand	28.49	32.64	-12.72
receivables turnover	3.23	4.64	-30.45
payables turnover	0.8	0.79	1.29
inventory turnover	3.16	2.76	14.57
roe	0.08	0.07	11.53
capex per share	0.3	0.46	-34.64

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 3.85 on 2024-06-30 Q2 from 3.25 on 2023-12-31 Q4, representing a change of 18.28%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.13 on 2024-06-30 Q2 from 1.20 on 2023-12-31 Q4, representing a change of -5.53%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.19 on 2024-06-30 Q2 from 0.13 on 2023-12-31 Q4, representing a change of 49.93%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None